SOLID TUMOR (PHASE I)
Clinical trials for SOLID TUMOR (PHASE I) explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR (PHASE I) trials appear
Sign up with your email to follow new studies for SOLID TUMOR (PHASE I), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Hard-to-Treat cancers with KRAS mutation
Disease control Not yet recruitingThis phase I trial tests an experimental oral drug called ABSK211 in people with advanced solid tumors that have a KRAS gene alteration. The study aims to find a safe dose and see how well the drug works. Participants take ABSK211 by mouth once daily in 21-day cycles.
Matched conditions: SOLID TUMOR (PHASE I)
Phase: PHASE1 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Smart drug targets two cancer weaknesses at once
Disease control Not yet recruitingThis trial tests a new drug called AN4035 in people with advanced solid tumors that have RAS mutations and high levels of the CEACAM5 protein. The drug is designed to seek out cancer cells carrying CEACAM5 and deliver a payload that blocks RAS, a key driver of cancer growth. The …
Matched conditions: SOLID TUMOR (PHASE I)
Phase: PHASE1 • Sponsor: Adlai Nortye Biopharma Co., Ltd. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC